プレマーケット: 4.96 -0.13 -2.55%

Eliem Therapeutics Inc (ELYM)

Eliem Therapeutics Inc (ELYM) 最新ニュース

Eliem Therapeutics Inc (ELYM)

Eliem Therapeutics Inc (ELYM) 最新ニュース

Monitoring Eliem Therapeutics Inc (ELYM) after recent insider movements - Knox Daily

Eliem Therapeutics Inc (ELYM) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Ratio Analysis: Unpacking Eliem Therapeutics Inc (ELYM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Shares Sold by Driehaus Capital Management LLC - MarketBeat

Selling Eliem Therapeutics Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St

Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m - Yahoo Finance

Eliem Therapeutics Inc (ELYM) can make a big difference with a little luck - SETE News

Eliem Therapeutics Inc (ELYM) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Affinity Asset Advisors LLC Takes $11.88 Million Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat

Trading (ELYM) With Integrated Risk Controls - Stock Traders Daily

500,000 Shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Acquired by Ally Bridge Group NY LLC - MarketBeat

Eliem Therapeutics: Recent Strategic Pipeline Restructuring (NASDAQ:ELYM) - Seeking Alpha

Closing Figures: Eliem Therapeutics Inc (ELYM)’s Positive Finish at 8.43, Up 1.81 - The Dwinnex

Eliem Therapeutics Inc (ELYM)’s stock price in review: A technical analysis - US Post News

Eliem therapeutics executive sells over $9,000 in company stock - Investing.com

Eliem therapeutics executive sells over $9,000 in company stock - Investing.com India

Eliem therapeutics executive sells over $9,000 in company stock By Investing.com - Investing.com Canada

(ELYM) Trading Signals - Stock Traders Daily

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - GlobeNewswire

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan

Eliem Therapeutics (NASDAQ:ELYM) Trading Up 4.6% - MarketBeat

Eliem Therapeutics Inc [ELYM] Investment Appeal on the Rise - Knox Daily

ELYM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

A Guide To The Risks Of Investing In Eliem Therapeutics Inc (ELYM) - Knox Daily

Eliem Therapeutics appoints Kaplan as COO; Rampal as SVP, Clinical Development - MSN

Eliem Therapeutics announces executive changes, refocuses on autoimmune diseases - Investing.com India

Eliem Therapeutics announces executive changes, refocuses on autoimmune diseases - Investing.com

Eliem Therapeutics: Executive Changes Amid Strategic Shift - TipRanks

Eliem Therapeutics expands executive team with new COO and SVP - Investing.com

Eliem Therapeutics appoints new COO Brett Kaplan - Investing.com

Eliem Therapeutics expands executive team with new COO and SVP - Investing.com India

Eliem Therapeutics appoints new COO Brett Kaplan By Investing.com - Investing.com UK

Eliem Therapeutics Names Brett Kaplan as New COO - TipRanks

Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire

Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire Inc.

ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024 - MSN

(ELYM) Long Term Investment Analysis - Stock Traders Daily

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest Up 34.0% in July - Defense World

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest Up 34.0% in July - MarketBeat

Analyzing Eliem Therapeutics Inc (ELYM) After Recent Trading Activity - Knox Daily

Eliem Therapeutics Reports Second Quarter Financial Results - ForexTV.com

Eliem Therapeutics Reports Second Quarter Financial Results - GlobeNewswire

Eliem Therapeutics Reports Second Quarter Financial Results - Yahoo Finance

Sciatica Treatment Industry is Expected to Reach Rapid Growth - openPR

ELYM’s 2023 Market Dance: Up 124.07% – Time to Invest? - The InvestChronicle

Daily Progress: Eliem Therapeutics Inc (ELYM) Drop -15.50, Closing at 6.05 - The Dwinnex

Recent Insider Activity Could Benefit Eliem Therapeutics Inc (ELYM) - Knox Daily

How To Trade (ELYM) - Stock Traders Daily

Where are the Opportunities in (ELYM) - Stock Traders Daily

Eliem Therapeutics, Inc. (NASDAQ:ELYM) Sees Significant Growth in Short Interest - MarketBeat

Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Valerie Morisset Sells 60,201 Shares - Defense World

Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Valerie Morisset Sells 69,005 Shares - Defense World

Insider Sale at Eliem Therapeutics Inc: EVP, R&D AND CSO Valerie Morisset Sells Shares - Yahoo Finance

Insider Sale at Eliem Therapeutics Inc: EVP, R&D AND CSO Valerie Morisset Sells Shares By GuruFocus - Investing.com Canada

Insider Selling: Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Sells 60,201 Shares of Stock - MarketBeat

Eliem Therapeutics Inc’s latest rating changes from various analysts - Knox Daily

ELYM: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle

Valerie Morisset Sells 3,207 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) Stock - American Banking and Market News

Eliem Therapeutics, Inc. (NASDAQ:ELYM) EVP Valerie Morisset Sells 3,207 Shares of Stock - Defense World

Valerie Morisset Sells 3,207 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) Stock - MarketBeat

Insider Sale at Eliem Therapeutics Inc (ELYM): EVP, R&D AND CSO Valerie Morisset Sells ... - Yahoo Finance

Insider Sale at Eliem Therapeutics Inc (ELYM): EVP, R&D AND CSO Valerie Morisset Sells ... By GuruFocus - Investing.com Canada

Eliem Therapeutics EVP sells over $289k in company stock - Investing.com

Valerie Morisset Sells 42,377 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) Stock - American Banking and Market News

ELYMに似た銘柄